Top 10 Most Expensive Drugs In The World
Some pharmaceutical products cost hundreds of thousands of dollars annually, making them a big business. As a result, we have ranked the ten treatments that cost the most worldwide in order of how much it would cost to treat each drug for a year.
The cost of pharmaceutical products has always divided opinion. The $2 million treatment offered by Novartis has received a lot of attention in recent years, but it may not even be the most expensive treatment available. Continue reading to learn why.
Top 10 Most Expensive Drugs
- Soliris
- Ravicti
- Blincyto
- Brineura
- Folotyn
- Luxturna
- Myalept
- Danyelza
- Zokinvy
- Zolgensma
1. Soliris $678,000
Alexion Pharmaceuticals, a division of AstraZeneca, is responsible for the development of Soliris. A healthcare professional injects it into the vein, and the annual cost is just over $678,000 (almost £500,000). If left untreated, NMOSD, also known as Devic disease, causes inflammation of the optic and spinal cords. The drug treats it.
9. Ravicti $700,000
Hyperion Therapeutics' Ravicti medication treats urea cycle disorder, a condition in which a lack of liver enzymes prevents a patient from disposing of waste nitrogen. It is self-administered every day with an oral syringe and costs just shy of $700,000 (£509,000) per year.
8. Blincyto $712,000
Although a vial of Amgen's Blincyto drug costs just over $4,400, a year of treatment would still cost approximately $712,000 (£520,000). B-precursor acute lymphoblastic leukemia is the blood cancer that is treated with this treatment, which is administered intravenously over the course of 28 days. Because it affects the B lymphocytes—white blood cells that develop in the bone marrow—this type of cancer is known as this.
7. Brineura $730,000
READ ALSO » Top 10 Deadliest Street Drugs In The World
Brineura is used to treat CLN2 disease, which is a genetic condition that affects the nervous system and typically causes epilepsy and ataxia. It is given by injecting it into the brain via an intraventricular injection. Every two weeks, a carton of Brineura from BioMarin Pharmaceutical is needed, which costs around $730,000 (approximately £535,000) annually.
6. Folotyn $795,000
The medication made by Acrotech Biopharma is used to treat T-cell lymphoma that has already spread. Patients who have relapsed or who have tried other treatments without success are the ideal candidates for this treatment. It is given intravenously once every week for six weeks. After that, there is a week of rest before the cycle starts all over again. The medication costs just over £580,000 per year, or almost $795,000.
5. Luxturna $850,000
Spark Therapeutics is the company that developed Luxturna. Due to the fact that it is a one-time treatment that involves being injected into the eye by a surgeon, despite the fact that it costs $850,000 (just over £620,000), it may be less expensive than the drugs that came before it. Retinal dystrophy, a condition that has the potential to lead to blindness, can be treated with this therapy in both children and adults.
4. Myalept $890,000
AstraZeneca's Myalept is taken once a day, and the typical patient requires approximately 14 vials every month. As a result, Myalept costs just under $890,000 per year, or almost £660,000. Patients with congenital generalized lipodystrophy, a rare condition in which almost all body fat is lost before or shortly after birth, are treated with the drug.
3. Danylza $977,000
Danylza is an infusion-based treatment for neuroblastoma, a rare cancer that mostly affects infants. It is manufactured by Y-mAbs Therapeutics. The disease is caused by nerve cells, or neuroblasts, that the mother left behind when the baby was born. Each dial of Danyelza costs just over $20,000, and patients typically require approximately 48 vials per year, making the annual cost $977,000 (£715,000).
2. Zokinvy $1,032,480
The Zokinvy medication manufactured by Eiger BioPharmaceuticals is the first and only treatment available for children over the age of 12 who suffer from progeria. Progeria is a rare genetic condition that makes young people seem to age much faster than usual. A year's supply of Zokinvy costs more than one million dollars, or $1,032,480 (£755,935), and it is taken orally twice daily.
1. Zolgensma $2,125,000
Zolgensma, which Novartis developed, is technically the most expensive drug in the world. However, unlike Luxturna, it is taken in a single dose, making it ultimately more cost-effective than many other medications. A medical professional administers it as an intravenous infusion to children with spinal muscular atrophy, a degenerative condition that eventually weakens the muscles and makes it difficult to move. The medication costs $2,125,000, or just over £1,500,000.
READ ALSO » Top 7 Ways To Reduce High Blood Pressure Without Drugs
